At the news
? NEUTRALIMPACT 3/10 DEFA14A filed Mar 26, 2026 at 16:06 ET
Edwards Lifesciences Corp filed a definitive proxy statement (DEFA14A) for its 2026 Annual Meeting of Stockholders, scheduled for May 7, 2026. The filing outlines four proposals for shareholder vote: election of nine directors, an advisory vote on executive compensation, ratification of the independent auditor, and approval of an amended long-term stock incentive program. The board recommends voting in favor of all proposals.
- Filing is a definitive proxy statement (DEFA14A) for the 2026 Annual Meeting of Stockholders.
- Meeting is scheduled for May 7, 2026, and will be held via webcast.
- Proposals include the election of nine directors, an advisory vote on executive compensation, ratification of the independent auditor, and approval of an amended long-term stock incentive program.
- The board of directors recommends a vote in favor of all proposals.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access